With More Cash from Wisconsin, GenTel Will Roll Out Pre-Spotted Diagnostic Array in 06 | GenomeWeb

GenTel BioSurfaces took another step towards commercializing a line of pre-spotted antibody arrays late last month by securing a $250,000 loan from the state of Wisconsin.

Made available through the state's Venture Capital Fund, which offers low-interest loans to local companies, the extra cash is part of a larger push by the Madison, Wisc.-based firm to bring a diagnostic array to market by early 2006, according to GenTel's CEO Alex Vodenlich.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.